Akoustis Technologies Inc. (AKTS)
$20.23
$-0.35
(-1.70%)
As on 27-May-2026 12:38EDT
Market cap
$1,124 Mln
Revenue (TTM)
$23 Mln
P/E Ratio
--
P/B Ratio
2.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.3 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
-0.1
-
Book Value
$--
-
EPS
$-1.2
-
Face value
--
-
Shares outstanding
53,404,618
10 Years Aggregate
CFO
$-180.21 Mln
EBITDA
$-253.51 Mln
Net Profit
$-278.92 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Akoustis Technologies (AKTS)
| -- | -4.8 | 3.1 | -- | 88.7 | 17.0 | 17.2 |
|
BSE Sensex
| -10.4 | -1.0 | -7.8 | -7.7 | 6.7 | 8.3 | 11.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
Akoustis Technologies (AKTS)
| -70.4 | -57.8 | -45.4 | 52.9 | 61.0 | -20.1 | 6.0 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Akoustis Technologies (AKTS)
|
20.2 | 1,124.3 | 6.5 | -63.7 | -186.6 | 54.5 | -- | 2.2 |
| 142.1 | 11,025.3 | 1,617.0 | 118.1 | 10.4 | 13.1 | 95.5 | 11.8 | |
| 329.6 | 12,997.9 | 1,905.2 | 190.5 | 8.3 | 14.2 | 67.5 | 9.4 | |
| 183.2 | 14,563.3 | 507.0 | -43.3 | -9.5 | -5.2 | -- | 12.8 | |
| 477.3 | 11,645.0 | 2,489.0 | -40.1 | -1.2 | -1.5 | -- | 4.6 | |
| 204.6 | 13,365.8 | 5,995.4 | 286.6 | 11.5 | 4.2 | 46.7 | 2.0 | |
| 357.4 | 12,215.4 | 471.7 | 136.7 | 20.8 | 19.7 | 89.3 | 16.2 | |
| 403.8 | 16,418.7 | 7,241.2 | 496.0 | 10.1 | 14.6 | 33.1 | 5.9 | |
| 381.9 | 15,253.5 | 7,241.2 | 496.0 | 10.1 | 14.6 | 30.8 | 5.5 | |
| 367.9 | 17,707.6 | 24,247.4 | 675.7 | 5.4 | 13.5 | 25.8 | 3.5 |
Shareholding Pattern
View DetailsAbout Akoustis Technologies (AKTS)
Aktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers. The company's lead product candidate includes... [225Ac]Ac-AKY-1189, a miniprotein radioconjugate platform which is in ongoing Phase 1b clinical trial for the treatment of Nectin-4 expressing solid tumors, including locally advanced or metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and [225Ac]Ac-AKY-2519 to deliver 225Ac to B7-H3 (CD276) expressing tumors, including prostate, lung and other solid tumors. It has license and collaboration agreements with Protein Innovation, Inc., TRIUMF Innovations, Inc., and Eli Lilly. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is headquartered in Boston, Massachusetts. Address: 17 Drydock Avenue, Boston, MA, United States, 02210 Read more
-
Founder, President, CEO & Director
Mr. Jeffrey B. Shealy
-
Founder, President, CEO & Director
Mr. Jeffrey B. Shealy
-
Headquarters
Boston, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Akoustis Technologies (AKTS)
What is the current share price of Akoustis Technologies Inc (AKTS) Today?
The share price of Akoustis Technologies Inc (AKTS) is $20.23 (NASDAQ) as of 27-May-2026 12:38 EDT. Akoustis Technologies Inc (AKTS) has given a return of 88.72% in the last 3 years.
What is the current PB & PE ratio of Akoustis Technologies Inc (AKTS)?
Since, TTM earnings of Akoustis Technologies Inc (AKTS) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
--
|
--
|
|
2024
|
-0.04
|
-0.02
|
|
2024
|
--
|
--
|
|
2023
|
-2.13
|
-1.32
|
|
2023
|
--
|
--
|
What is the 52 Week High and Low of Akoustis Technologies Inc (AKTS)?
The 52-week high and low of Akoustis Technologies Inc (AKTS) are Rs 23.36 and Rs 14.72 as of 27-May-2026.
What is the market cap of Akoustis Technologies Inc (AKTS)?
Akoustis Technologies Inc (AKTS) has a market capitalisation of $ 1,124 Mln as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Akoustis Technologies Inc (AKTS)?
Before investing in Akoustis Technologies Inc (AKTS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.